Aggressive variants of papillary thyroid cancer

Current Opinion in Oncology

Volumn 25, Issue 1, 2013, Pages 33-38

  Roman, Sanziana ^a   Sosa, Julie A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggressive variants of papillary thyroid cancer; Diffuse sclerosing variant; Insular thyroid cancer; Tall cell variant

Indexed keywords

B RAF KINASE; MOLECULAR MARKER; RADIOACTIVE IODINE;

ANAPLASTIC THYROID CANCER; CANCER PROGNOSIS; CANCER REGISTRY; CYTOREDUCTIVE SURGERY; DIFFERENTIATED THYROID CANCER; DIFFUSE SCLEROSING VARIANT; DISEASE SPECIFIC SURVIVAL; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GENETIC MARKER; HISTOPATHOLOGY; HUMAN; INSULAR THYROID CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POORLY DIFFERENTIATED THYROID CANCER; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; TALL CELL VARIANT; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; SCLEROSIS; THYROID NEOPLASMS;

EID: 84871960495     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32835b7c6b     Document Type: Review

References (24)

1. Clark OH. Thyroid cancer and lymph node metastases. J Surg Oncol 2011; 1003:615-618
2. Volante M, Collini P, Nikiforov Y, et al. Poorly differentiated thyroid carcinoma: The Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007; 31: 1256-1264
3. DeLellis RA, Loyd RV, Heitz PU, Eng C. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004
4. Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas: How much poorly differentiated is needed? Am J Surg Pathol 2011; 35:1866-1872
5. Carling T, Ocal I, Udelsman R. Special variants of differentiated thyroid cancer: Does it alter the extent of surgery versus well differentiated thyroid cancer? World J Surg 2007; 31:916-923
6. Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M. Papillary carcinoma. Semin Diagn Pathol 1985; 2:90-100
7. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 1989; 13:1041-1049
8. Kazaure HS, Roman SA, Sosa JA. Aggressive variants of papillary thyroid cancer: Incidence, characteristics and predictors of survival among 43,738 patients. Ann Surg Oncol 2012; 19:1874-1880
9. Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid 2009; 19:1225- 1231
10. Regalbuto C, Malandrino P, Tumminia A, et al. A diffuse sclerosing variant of papillary thyroid carcinoma: Clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid 2011; 21:383-389
11. Zhang Y, Xia D, Lin P, et al. Sonographic findings of the diffuse sclerosing variant of papillary carcinoma of the thyroid. J Ultrasound Med 2010; 29:1223-1226
12. Bongiovanni M, Triponez F, McKee T, et al. Fine-needle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis: A potential pitfall. Diagn Cytopathol 2009; 37:671- 675
13. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q 1976; 43:207-215
14. Silver C, Owen R, Rodrigo J, et al. Aggressive variants of papillary thyroid carcinoma. Head Neck 2011; 7:1052-1059
15. Choi Y, Shin J, Kim J, et al. Tall cell variant of papillary thyroid carcinoma: Sonographic and clinical findings. J Ultrasound Med 2011; 30:853- 858
16. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ('insular') thyroid carcinoma. A reinterpretation of Langhans' 'wuchernde Struma'. Am J Surg Pathol 1984; 8:655-668
17. Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol 2004; 86:44-54
18. Kazaure HS, Roman SA, Sosa JA. Insular thyroid cancer: A population-level analysis of patient characteristics and predictors of survival. Cancer 2012; 118:3260-3267
19. Xing M. BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28:742-762
20. Lloyd R, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol 2011; 5:51-56
21. Virk RK, Van Dyke AL, Finkelstein A, et al. BRAF (V600E) mutation in papillary thyroid microcarcinoma: A genotype-phenotype correlation. Mod Pathol 2012 [Epub ahead of print].
22. Soares P, Lima J, Preto A, et al. Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics 2011; 12:609-617
23. Ricarte-Filho JC, Ryder M, Chitale DA, et al. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res 2009; 69:4885-4893
24. Prazeres H, Torres J, Rodrigues F, et al. Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene 2011; 30:1302-1317.